SecSonar.com

vTv Therapeutics Inc. (VTVT)

vTv Therapeutics Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

vTv Therapeutics Inc. (VTVT) is a Biotechnology company based in US with a market capitalization of $86.7M. Free cash flow was negative at -$25.3M. This page tracks VTVT's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 23 employees · IPO Jul 30, 2015

Valuation

Valuation & price

$35.70 · as of May 17, 2026 · -16.4% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

1.35

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$42.72$28.38$14.03Jul 25Dec 25Jul 26Jul 7, 25$14.90Jul 9, 25$16.46Jul 11, 25$17.01Jul 15, 25$16.88Jul 17, 25$16.16Jul 21, 25$16.77Jul 23, 25$17.03Jul 25, 25$15.54Jul 29, 25$15.09Jul 31, 25$14.95Aug 4, 25$14.47Aug 6, 25$14.62Aug 11, 25$15.47Aug 13, 25$14.03Aug 15, 25$15.44Aug 19, 25$15.52Aug 21, 25$14.98Aug 25, 25$16.00Aug 27, 25$16.24Aug 29, 25$16.24Sep 3, 25$18.87Sep 5, 25$18.31Sep 9, 25$18.77Sep 11, 25$20.06Sep 16, 25$21.18Sep 18, 25$21.35Sep 22, 25$22.17Sep 24, 25$22.18Sep 26, 25$22.33Sep 30, 25$23.35Oct 2, 25$23.13Oct 6, 25$22.59Oct 8, 25$22.12Oct 10, 25$21.86Oct 14, 25$21.81Oct 16, 25$20.79Oct 21, 25$21.00Oct 23, 25$20.84Oct 27, 25$21.19Oct 29, 25$21.07Oct 31, 25$21.75Nov 4, 25$24.92Nov 6, 25$25.47Nov 10, 25$27.99Nov 12, 25$31.00Nov 14, 25$30.80Nov 18, 25$30.11Nov 20, 25$31.53Nov 25, 25$27.88Nov 28, 25$26.70Dec 2, 25$25.24Dec 4, 25$27.37Dec 8, 25$30.51Dec 10, 25$34.41Dec 12, 25$34.63Dec 16, 25$35.14Dec 18, 25$34.72Dec 22, 25$36.65Dec 24, 25$37.01Dec 29, 25$37.97Jan 2, 26$39.60Jan 6, 26$42.72Jan 8, 26$41.06Jan 12, 26$34.12Jan 14, 26$40.01Jan 16, 26$35.59Jan 21, 26$33.05Jan 23, 26$34.11Jan 27, 26$34.01Jan 29, 26$34.15Feb 2, 26$38.31Feb 4, 26$36.41Feb 9, 26$31.66Feb 11, 26$34.39Feb 13, 26$33.87Feb 18, 26$37.23Feb 20, 26$34.30Feb 24, 26$39.83Feb 26, 26$39.32Mar 2, 26$35.60Mar 4, 26$36.00Mar 6, 26$35.41Mar 10, 26$35.02Mar 12, 26$33.71Mar 17, 26$36.70Mar 19, 26$35.97Mar 23, 26$37.28Mar 25, 26$38.30Mar 27, 26$38.51Mar 31, 26$39.66Apr 2, 26$41.17Apr 7, 26$38.25Apr 9, 26$37.30Apr 13, 26$37.10Apr 15, 26$37.72Apr 17, 26$38.12Apr 22, 26$40.45Apr 24, 26$32.76Apr 28, 26$31.97Apr 30, 26$32.24May 4, 26$32.50May 6, 26$31.68May 8, 26$30.68May 12, 26$32.11May 14, 26$38.43May 18, 26$35.49May 20, 26$36.60May 22, 26$34.41May 28, 26$33.50Jun 1, 26$34.30Jun 3, 26$32.94Jun 5, 26$32.14Jun 9, 26$31.77Jun 11, 26$31.59Jun 15, 26$33.54Jun 17, 26$33.92Jun 22, 26$33.92Jun 24, 26$35.74Jun 26, 26$35.08Jul 2, 26$35.40
$14.0052-week range$42.72
Loading valuation history…

Fundamentals

Key fundamentals

$86.7M

Market cap

—

Revenue growth (YoY)

100.0%

Gross margin

-$25.3M

Free cash flow (USD)

-$88.9M

Net debt

Net cash position

46.0%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$634.0KFY 2017$291.0KFY 2018$12.4MFY 2019$2.8MFY 2020$6.4MFY 2021$4.0MFY 2022$2.0MFY 2023$0.00FY 2024$1.0MFY 2025$0.00
$634K$0

Free cash flow by year

2016 → 2025

FY 2016$-48.3MFY 2017$-44.6MFY 2018$-26.9MFY 2019$-23.1MFY 2020$-18.0MFY 2021$-19.3MFY 2022$-15.3MFY 2023$-19.1MFY 2024$-25.3MFY 2025$-25.3M
-$48.3M-$25.3M

Gross margin by year

2021 → 2024

FY 2021100.0%FY 2022100.0%FY 2024100.0%
100.0%100.0%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 13, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventAnnual Meeting ResultsJun 29, 2026Filing
  • 8-K eventEarnings ReleaseMay 13, 2026Filing
  • Quarterly report10-Q FiledMay 13, 2026Filing
  • 8-K eventShare Offering IncreaseMay 13, 2026Filing

Questions

Frequently asked questions

What is vTv Therapeutics Inc.'s market cap?

vTv Therapeutics Inc. (VTVT) has a market capitalization of $86.7M.

What is VTVT's P/E ratio?

A meaningful P/E ratio is not available for VTVT — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is VTVT's price-to-book (P/B) ratio?

VTVT trades at 1.35 times book value per share.

Are insiders buying VTVT stock?

SEC Form 4 filings show no open-market insider buys at vTv Therapeutics Inc. in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

COYA

Coya Therapeutics, Inc.

$86.3M

DTIL

Precision BioSciences, Inc.

$89.5M

ICCC

ImmuCell Corporation

$89.6M

NRXS

NeurAxis, Inc.

$89.9M

GANX

Gain Therapeutics, Inc.

$82.5M

HYFT

MindWalk Holdings Corp.

$82M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.